Veradigm | MDRX - Interest Expense On Debt


Veradigm reported $1.25M in Interest Expense on Debt for its fiscal quarter ending in September of 2022.





Interest Expense On Debt Change Date
Alcidion AUD 32K 9K Dec/2025
Ambu A/S DKK 15M 14M Dec/2025
Amplifon EUR 14.64M 106K Sep/2025
Cardinal Health USD 88M 8M Dec/2025
Centene USD 168M 2M Dec/2025
Charles River Laboratories USD 23.78M 1.63M Dec/2025
Cigna USD 157.92B 460K Dec/2025
Coloplast 164M 0 Dec/2025
Computer Programs Systems USD 2.87M 911K Dec/2025
CVS Health USD 787M 3M Dec/2025
Diasorin EUR 5.25M 2.25M Sep/2025
Elevance Health USD 357M 9M Mar/2026
General Electric Aerospace USD 496M 271M Dec/2025
Gulf Medical Proj AED 33K 9K Sep/2024
Humana USD 146M 22M Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
Laboratory Of America USD 55M 1000K Dec/2025
Maximus USD 20.82M 1.84M Dec/2025
McKesson USD 63M 11M Dec/2025
Med Life RON 24.78M 2.15M Dec/2023
Molina Healthcare USD 54M 2M Mar/2026
Omnicell USD 522K 558K Sep/2025
Oriola-kd EUR 2M 200K Dec/2025
Owens Minor USD 27.93M 1.1M Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Rede D'or Sao Luiz BRL 1.5B 2.05B Dec/2025
Siemens Healthineers EUR 96M 12M Dec/2025
Sonova Holding CHF 24.2M 3.7M Jun/2025
Supermax Corporation Bhd MYR 1.66M 1.44M Sep/2025
UnitedHealth USD 955M 19M Mar/2026
Veeva Systems USD 65.1M 8.4M Mar/2025
Veradigm USD 1.25M 641K Sep/2022
Xerox USD 31M 0 Dec/2024